paper: Marais, C., Claude, C., Semaan, N., Charbel, R., Barreault, S., Travert, B., Piloquet, J., Demailly, Z., Morin, L., Merchaoui, Z., Teboul, J., Durand, P., Miatello, J. and Tissières, P. (2021). Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study. Ann Intensive Care https://www.ncbi.nlm.nih.gov/pubmed/34259942/
contributor: Pierre Tissières
contributor_organization: AP-HP/Université Paris Saclay/Inserm
contributor_email: pierre.tissieres@aphp.fr
contributor: Pierre Tissières
contributor_organization: AP-HP/Université Paris Saclay/Inserm
contributor_email: pierre.tissieres@aphp.fr
- description: Circulating myeloid cells phenotypes of adult COVID-19 critically ill patients.
- exact_source: Figure 3
- tissue: circulating myeloid cells
- immune_exposure: Covid-19 infection
- cohort: Adults
- comparison: Alive vs dead and secondary infection vs no secondary infection
- repository_id:
- platform:
- response_components: m-MDSC, myeloid cells, mHLA-DR, CD11b+HLADR+, CD11b- HLADR+
- response_behavior: up